organophosphonates has been researched along with Chronic Delta Hepatitis in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (20.00) | 29.6817 |
2010's | 12 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brichler, S; Renou, C; Setshedi, M | 1 |
Gunsar, F | 1 |
Price, J | 1 |
Gervain, J; Horváth, G; Hunyady, B; Lengyel, G; Makara, M; Pár, A; Szalay, F; Telegdy, L; Tornai, I | 1 |
Barreiro, P; Fernández-Montero, JV; Labarga, P; Mendoza, Cd; Sierra-Enguita, R; Soriano, V; Vispo, E | 1 |
Bozkaya, H; Dalekos, GN; Deda, X; Gürel, S; Heidrich, B; Idilman, R; Keskin, O; Manns, M; Pehlivan, S; Tabak, F; Tüzün, A; Wedemeyer, H; Yalçın, K; Yurdaydin, C; Zachou, K; Zeuzem, S | 1 |
Goyal, A; Murray, JM | 1 |
Akriviadis, E; Antoniadis, N; Cholongitas, E; Fouzas, I; Giakoustidis, D; Giouleme, O; Goulis, I; Imvrios, G; Papanikolaou, V; Vasiliadis, T | 1 |
Moreno, V; Valencia, ME | 1 |
Abgueguen, P; Calès, P; Ducancelle, A; Gordien, E; Le Gal, F; Le Guillou-Guillemette, H; Lunel, F; Mansour, W; Pivert, A | 1 |
Bonnard, P; Boyd, A; Girard, PM; Lacombe, K; Lascoux-Combe, C; Lasnier, E; Meynard, JL; Miailhes, P; Molina, JM; Wendum, D | 1 |
Bock, T; Bozkaya, H; Çakaloğlu, Y; Dalekos, GN; Değertekin, H; Dienes, HP; Erhardt, A; Gürel, S; Koch, A; Manns, MP; Wedemeyer, H; Yurdaydìn, C; Zachou, K; Zeuzem, S | 1 |
Buggisch, P; Cornberg, M; Grabowski, J; Hofmann, WP; Jaroszewicz, J; Manns, MP; Schlaphoff, V; Wedemeyer, H; Yurdaydìn, C; Zachou, K | 1 |
Ferenci, P | 1 |
Grattagliano, I; Palasciano, G; Palmieri, VO; Portincasa, P | 1 |
3 review(s) available for organophosphonates and Chronic Delta Hepatitis
Article | Year |
---|---|
Treatment of delta hepatitis.
Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Farnesyl-Diphosphate Farnesyltransferase; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis D, Chronic; Hepatitis delta Antigens; Hepatitis Delta Virus; Humans; Interferon-alpha; Organophosphonates; Polyethylene Glycols; Protein Prenylation; Recombinant Proteins; Viral Proteins; Virus Replication | 2013 |
An update on hepatitis B, D, and E viruses.
Topics: Adenine; Drug Therapy, Combination; Guanine; Hepatitis B, Chronic; Hepatitis D, Chronic; Hepatitis E; Humans; Interferon-alpha; Liver Cirrhosis; Liver Failure; Organophosphonates; Tenofovir; Treatment Outcome | 2014 |
Treatment of chronic viral hepatitis.
Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis D, Chronic; Humans; Interferon-alpha; Lamivudine; Organophosphonates | 2004 |
3 trial(s) available for organophosphonates and Chronic Delta Hepatitis
Article | Year |
---|---|
Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome.
Topics: Adenine; Adult; Antiviral Agents; Biopsy; DNA, Viral; Female; Hepatitis B Surface Antigens; Hepatitis D, Chronic; Hepatitis Delta Virus; Humans; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Placebos; Polyethylene Glycols; Recombinant Proteins; RNA, Viral; Transaminases; Treatment Outcome; Viral Load | 2015 |
Peginterferon plus adefovir versus either drug alone for hepatitis delta.
Topics: Adenine; Adult; Aged; Alanine Transaminase; Analysis of Variance; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis B Surface Antigens; Hepatitis D, Chronic; Hepatitis Delta Virus; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; RNA, Viral; Viral Load; Young Adult | 2011 |
Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment.
Topics: Adenine; Adult; Analysis of Variance; Antiviral Agents; Cells, Cultured; Chi-Square Distribution; Cytokines; Drug Therapy, Combination; Europe; Female; Hepatitis D, Chronic; Hepatitis Delta Virus; Humans; Interferon-alpha; Leukocytes, Mononuclear; Male; Middle Aged; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; RNA, Viral; Time Factors; Treatment Outcome; Viral Load; Young Adult | 2011 |
9 other study(ies) available for organophosphonates and Chronic Delta Hepatitis
Article | Year |
---|---|
Resolution of chronic hepatitis delta infection after five years of peginterferon-adefovir: lessons from a case report.
Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Hepatitis D, Chronic; Hepatitis delta Antigens; Hepatitis Delta Virus; Humans; Interferon-alpha; Male; Middle Aged; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; RNA, Viral | 2013 |
[Diagnosis and treatment of chronic hepatitis B and D. Hungarian national consensus guideline].
Topics: Adenine; Antiviral Agents; Consensus; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis D, Chronic; Hepatitis Delta Virus; Humans; Hungary; Interferon-alpha; Lamivudine; Liver Neoplasms; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Tenofovir | 2014 |
Efficacy of prolonged tenofovir therapy on hepatitis delta in HIV-infected patients.
Topics: Adenine; Adult; Antiviral Agents; Hepatitis D, Chronic; HIV Infections; Humans; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Retrospective Studies; RNA, Viral; Tenofovir; Treatment Outcome; Viral Load | 2014 |
Cost-Effectiveness of Peg-Interferon, Interferon and Oral Nucleoside Analogues in the Treatment of Chronic Hepatitis B and D Infections in China.
Topics: Adenine; Adult; Age Factors; Aged; Antiviral Agents; China; Cohort Studies; Cost of Illness; Cost-Benefit Analysis; Drug Costs; Female; Hepatitis B, Chronic; Hepatitis D, Chronic; Humans; Interferons; Male; Markov Chains; Middle Aged; Nucleosides; Organophosphonates; Palliative Care; Quality-Adjusted Life Years | 2016 |
Nucleos(t)ide analog(s) prophylaxis after hepatitis B immunoglobulin withdrawal against hepatitis B and D recurrence after liver transplantation.
Topics: Adenine; Adult; Antiviral Agents; Coinfection; DNA, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis D, Chronic; Humans; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Organophosphonates; Secondary Prevention; Tenofovir; Treatment Outcome; Withholding Treatment; Young Adult | 2016 |
[Atazanavir-induced nephrolithiasis].
Topics: Adenine; Adult; Alkynes; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis D, Chronic; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Lopinavir; Male; Nephrolithiasis; Oligopeptides; Organophosphonates; Pyridines; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Tenofovir | 2009 |
Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine.
Topics: Adenine; Antibodies, Viral; Antiviral Agents; Deoxycytidine; DNA, Viral; Drug Therapy, Combination; Emtricitabine; Hepatitis B; Hepatitis D, Chronic; Hepatitis Delta Virus; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; RNA, Viral; Tenofovir; Treatment Outcome | 2010 |
Liver fibrosis changes in HIV-HBV-coinfected patients: clinical, biochemical and histological effect of long-term tenofovir disoproxil fumarate use.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cohort Studies; DNA, Viral; Female; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C; Hepatitis D, Chronic; HIV Infections; Humans; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Tenofovir; Viral Load | 2010 |
Adefovir dipivoxyl for the treatment of delta-related liver cirrhosis.
Topics: Adenine; Female; Hepatitis D, Chronic; Hepatitis Delta Virus; Humans; Liver Cirrhosis; Middle Aged; Organophosphonates | 2006 |